Paclitaxel Polymeric Micelles for Injection Versus TPC on the Treatment of HER2-negative Metastatic Breast Cancer (MBC).
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer (MBC)
Interventions: DRUG: Paclitaxel Polymeric Micelles for Injection|DRUG: Eribulin Mesilate injection|DRUG: Capecitabine Tablets|DRUG: Gemcitabine Hydrochloride for Injection|DRUG: Vinorelbine Tartrate Injection|DRUG: Paclitaxel (albumin-bound)
Sponsor: Shanghai Yizhong Pharmaceutical Co., Ltd.